Beam stock forecast.

According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.There are four main types of forecasting methods that financial analysts use to predict future revenues, expenses, and capital costs for a business. While there are a wide range of frequently used quantitative budget forecasting tools, in this article we focus on four main methods: (1) straight-line, (2) moving average, (3) simple linear ...According to our current BEAM stock forecast, the value of Beam Therapeutics shares will drop by -2.93% and reach $ 28.70 per share by December 8, …NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25. beam stock forecast cnn. ... View the latest BEAM stock quote and chart on… Monday, November 14, 2022 Edit. caffeine light more roast. light roast coffee has more caffeine. Dark Roast Vs Light Roast Coffee November 14, 2022 Edit. nfl picks wallpaper week. sporting news nfl picks week 6.

See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...

Nov 22, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00. Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …Beam Therapeutics Stock Chart and Share Price Forecast, Short-Term "BEAM" Stock Prediction for Next Days and Weeks Walletinvestor.com Beam Therapeutics Inc (BEAM) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024The global welding market size was valued at USD 23.75 billion in 2022. The market is projected to grow from USD 24.73 billion in 2023 to USD 34.18 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. The welding industry has witnessed significant technological advancements in recent years, including the development of new ...John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...

Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.

Dec 1, 2023 · Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …Aug 26, 2023 · Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ... According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy.Dec 1, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...AUPH Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.20 with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 71.29% change from the last price of $8.29.Accel partner Amy Saper, who is also a former Stripe employee, led the financing for the five-month-old startup. Beam, a five-month-old startup out to more easily help general contractors pay subcontractors and get paid themselves, has rais...Drug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.Their consensus HOOD stock forecast was that it could hit $13.36, which would represent a potential upside of 39.28% over the $9.59 closing price on 20 November, 2022. The highest Robinhood stock forecast 2023 prediction came in at $28 and the lowest warned it could slip to just $7. HOOD stock was also a ‘hold’, according to the …

Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...Perform stock investment research with our IBD research tools to help investment strategies. We provide the resources to help make informed decisions.

Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80Pricing Details. The global bridge construction market size was valued at $857.7 billion in 2020, and is projected to reach $1,416.9 billion by 2030, registering a CAGR of 5.0% from 2021 to 2030. A bridge is a super-structure that spans horizontally between supports. The major function of a bridge is to carry vertical loads.Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time AI - C3.ai Inc stock quotes, company profile, news and forecasts from CNN Business.See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per …Nov 1, 2023 · Stock Forecast for the Price of an Beam Therapeutics Share in Jan 2025. In January 2025, analysts believe the stock price will be $21.77. An increase of 14.09% compared to the previous month's estimate. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...

Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ...

Drug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...

Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...0.99%. €17.62M. IBAB | Complete Ion Beam Applications S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Aug 29, 2023 · BEAM stock, belonging to Beam Therapeutics Inc, has shown promising performance on August 29, 2023, according to data from CNN Money. The 15 analysts offering 12-month price forecasts for BEAM stock have a median target of $56.00, with a high estimate of $105.00 and a low estimate of $32.00. BEAM Stock 12 Months Forecast. $43.44. (58.25% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The average price target is $43.44 with a high forecast of $75.00 and a low forecast of $19.00. The average price target represents a 58.25% change from the last price of $27.45. Beam Price Live Data. The live Beam price today is $0.164128 USD with a 24-hour trading volume of $6,003,743 USD. We update our BEAM to USD price in real-time. Beam is up 214.10% in the last 24 hours. The current CoinMarketCap ranking is #654, with a live market cap of $24,315,976 USD. It has a circulating supply of 148,152,520 BEAM coins and a ...Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...0.99%. €17.62M. IBAB | Complete Ion Beam Applications S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25. Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.

Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $102.85M. -16.4%. Market Cap / Employee. The market cap of a ...BEAM stock, the ticker symbol for Beam Therapeutics Inc, experienced a significant increase in its price on October 19, 2023. According to data from CNN Money, 14 analysts have provided 12-month price forecasts for the stock. The median target price is $61.00, with a high estimate of $105.00 and a low estimate of $27.00.18/10/2023. IBA plans total system restoration on its first-ever proton therapy installation. Analytical report. Stock ION BEAM APPLICATIONS Common Stock BE0003766806 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news.Instagram:https://instagram. reit vs rental propertyoptions to trade todayballard power systemstocks near 52 week lows Ring beams are a type of support used in construction to connect walls together and increase the load capacity for the walls. Ring beams surround the foundation, and walls are built upon the ring. In some projects, an additional ring beam i... is beagle 401k realtrading options in roth irabest dental discount plans BEAM Stock 12 Months Forecast. $43.44. (46.41% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The …Lumber increased 29.16 USD/1000 board feet or 5.87% since the beginning of 2023, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity. Lumber - values, historical data, forecasts and news - updated on December of 2023.Find real-time DOCU - DocuSign Inc stock quotes, company profile, news and forecasts from CNN Business.